Boston Scientific
BSX
BSX
563 hedge funds and large institutions have $29.4B invested in Boston Scientific in 2016 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 200 increasing their positions, 202 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
1% less repeat investments, than reductions
Existing positions increased: 200 | Existing positions reduced: 202
1.34% less ownership
Funds ownership: 93.15% → 91.81% (-1.3%)
30% less funds holding in top 10
Funds holding in top 10: 23 → 16 (-7)
Holders
563
Holding in Top 10
16
Calls
$87.9M
Puts
$52.3M
Top Buyers
| 1 | +$188M | |
| 2 | +$102M | |
| 3 | +$100M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$73M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$57.9M |
Top Sellers
| 1 | -$340M | |
| 2 | -$235M | |
| 3 | -$167M | |
| 4 |
O
OrbiMed
New York
|
-$141M |
| 5 |
Millennium Management
New York
|
-$82.2M |